Braze Inc vs Twist Bioscience Corp — how do they compare? Braze Inc trades at $27.77 (market cap $3.18B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 2.4× Braze Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.
| BRZE | TWST | |
|---|---|---|
Market Cap | $3.18B | $7.72B |
Sector | Technology | Health |
52-Week High | $36.19 | $124.88 |
52-Week Low | $15.79 | $24.16 |
Enterprise Value | $2.87B | $7.65B |
Trailing returns across standard periods
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.
Read more on BRZE →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →